Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01645319 · ClinicalTrials.gov registry record
Comparative Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma
A clinical trial of Open Angle Glaucoma, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- Completed
- Registry status
- 2,597
- Enrollment target
- 1
- Study location
NCT01645319 is a study of Open Angle Glaucoma that has completed, run by Agency for Healthcare Research and Quality (AHRQ). The registered enrollment target is 2,597 participants, above the 242-participant average among 28 other Open Angle Glaucoma trials with a reported enrollment target (973% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01645319, a study of Open Angle Glaucoma, has completed, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- COMPLETED
- Registry status
- 2,597 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objectives of the study are: 1. To compare the proportion of patients who achieve a successful response to treatment (reduction in Intraocular Pressure (IOP) of \>15%) between patients treated with laser surgery (including argon laser trabeculectomy, and selective laser trabeculoplasty) with patients receiving additional medications, at 1-year post-treatment initiation. 2. To compare the proportion of patients who achieve a successful response to treatment (reduction in IOP of \>15%) between patients treated with other procedures (including incisional surgery, drainage device procedures, and other glaucoma procedures) with patients receiving additional medications, at 1-year-post-treatment initiation. The study is a prospective, observational cohort study and will not provide or recommend any treatment. Patients who have failed initial medical therapy with two glaucoma medications will be identified and enrolled at the time of scheduling of a laser surgery procedure or other procedure such as incisional surgery or drainage device, or initiation of an additional course of therapy with medication as determined by their physician. This inception cohort of new initiators of laser surgical treatment, other procedures, or additional medical therapy will be followed for 12 months. All decisions regarding treatment are solely at the discretion of the physician in accordance with their usual practice. Enrollment is expected to begin in February 2011 and continue through 12 months of follow-up after enrollment targets have been reached.
Conditions Studied
Study Locations (1)
Pennsylvania
- Wills Eye Institute - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,597 participants |
| Start Date | 2011-02 |
| Est. Completion | 2013-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01645319
The ClinicalTrials.gov registry entry for NCT01645319 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,597 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 242-participant average among 28 other Open Angle Glaucoma trials with a reported enrollment target (973% higher). The listed sponsor is Agency for Healthcare Research and Quality (AHRQ), which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Open Angle Glaucoma appearing as the primary indexed condition, and to 0 interventions.
NCT01645319 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01645319 about?
NCT01645319 is a clinical study titled "Comparative Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma". The primary objectives of the study are: 1. To compare the proportion of patients who achieve a successful response to treatment (reduction in Intraocular Pressure (IOP) of \>15%) between patients treated with laser surgery (including argon laser trabeculectomy, and selective laser trabeculoplasty)...
What is the current status of trial NCT01645319?
This trial is currently completed. The enrollment target is 2,597 participants. The study started on 2011-02. Estimated completion is 2013-07.
What conditions does trial NCT01645319 study?
This clinical trial studies the following conditions: Open Angle Glaucoma.
Who is sponsoring clinical trial NCT01645319?
This trial is sponsored by Agency for Healthcare Research and Quality (AHRQ), which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01645319 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Open Angle Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
RECRUITING · Phase 4
-
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
RECRUITING · NA
-
Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost
RECRUITING · Phase 4
-
Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
RECRUITING · Phase 4
-
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
RECRUITING · Phase 1
-
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.